Amandeep S. Sidhu
Subscribe to Amandeep S. Sidhu's Posts
Amandeep (Aman) S. Sidhu focuses his practice on complex commercial disputes with an emphasis on regulated industries, including health care-related investigations and litigation. He represents hospitals and health care companies in investigations and defense of qui tam whistleblower litigation involving federal False Claims Act (FCA), Stark Laws and Anti-Kickback Statute in federal district courts throughout the United States. Aman regularly supports settlement negotiations with the US Department of Justice for clients in multiple jurisdictions, including negotiation of corporate integrity agreements with the US Department of Health and Human Services Office of Inspector General. Aman also represents health care and life sciences companies in the navigation of state and federal investigations, including responding to congressional inquiries. Aman serves on the Firm's Diversity/Inclusion Committee, Pro Bono and Community Service Committee and Associate Development Committee. Read Amandeep Sidhu's full bio.
DOJ Continues Telemedicine Enforcement in Q2 2019
By McDermott Will & Emery, Amandeep S. Sidhu and Marshall E. Jackson, Jr. on Aug 27, 2019
Posted In Telehealth
During the second quarter of 2019, DOJ continued its focus on enforcement activity in telemedicine. As reported in prior editions of the Quarterly Roundup, telemedicine is an expanding field, causing DOJ to pay particular attention to the industry. In April 2019, DOJ indicted the owner and operator of 1stCare MD and ProfitsCentric with one count...
Health Care Enforcement Roundup: Increased FCA Enforcement Against EHR Companies
By Amandeep S. Sidhu, James A. Cannatti III and Theodore Alexander on May 9, 2019
Posted In Uncategorized
The federal government has offered substantial incentives to providers to adopt and use certified electronic health record (EHR) technology. As of October 2018, the federal government had paid over $38 billion in EHR incentive payments through the Promoting Interoperability Program (formerly, the Meaningful Use Program). Other federal health care program policies also encourage use of...
DOJ’s Enforcement Activity Against Individuals: Acute Focus on Telemedicine
By Amandeep S. Sidhu, James A. Cannatti III and Theodore Alexander on May 6, 2019
Posted In Telehealth
DOJ’s focus on individual accountability is particularly important with respect to telemedicine. Telemedicine is a burgeoning field, with a projected market increase of 18 percent annually over the next six years, reaching $103 billion in 2024. In light of this recent surge in profitability, DOJ has begun paying extra attention to telemedicine, with at least...